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Abstract
Background: Methionine sulfoxide reduction is an important protein repair pathway that protects
against oxidative stress, controls protein function and has a role in regulation of aging. There are
two enzymes that reduce stereospecifically oxidized methionine residues: MsrA (methionine-Ssulfoxide reductase) and MsrB (methionine-R-sulfoxide reductase). In many organisms, these
enzymes are targeted to various cellular compartments. In mammals, a single MsrA gene is known,
however, its product is present in cytosol, nucleus, and mitochondria. In contrast, three mammalian
MsrB genes have been identified whose products are located in different cellular compartments.
Results: In the present study, we identified and characterized alternatively spliced forms of
mammalian MsrA. In addition to the previously known variant containing an N-terminal
mitochondrial signal peptide and distributed between mitochondria and cytosol, a second mouse
and human form was detected in silico. This form, MsrA(S), was generated using an alternative first
exon. MsrA(S) was enzymatically active and was present in cytosol and nucleus in transfected cells,
but occurred below detection limits in tested mouse tissues. The third alternative form lacked the
active site and could not be functional. In addition, we found that mitochondrial and cytosolic forms
of both MsrA and MsrB in Drosophila could be generated by alternative first exon splicing.
Conclusion: Our data suggest conservation of alternative splicing to regulate subcellular
distribution of methionine sulfoxide reductases.

Background
The sulfur atom of methionine residues is susceptible to
oxidation by reactive oxygen species. Oxidation of
methionines may affect protein structure and function
and has been implicated in various processes, such as oxidative stress, accelerated aging, and neurodegenerative
diseases (reviewed in [1-6]). This oxidation generates a
diastereomeric mixture of methionine-S-sulfoxide and
methionine-R-sulfoxide. In contrast to irreversible protein
oxidation, such as carbonylation, methionine sulfoxide
can be reversibly reduced back to methionine by repair

enzymes, methionine sulfoxide reductases. There are two
known classes of these enzymes: MsrA (methionine-S-sulfoxide reductase) and MsrB (methionine-R-sulfoxide
reductase). Although the catalytic mechanisms for MsrA
and MsrB are similar, these enzymes have different folds.
Most organisms from bacteria to humans encode MsrA
and MsrB genes in their genomes, however, some hyperthermophiles lack MsrA, MsrB, or both genes [7]. MsrA
and MsrB genes in several bacterial species are clustered
with each other and appear to form an operon. In addiPage 1 of 6
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Figurevariants
Splice
1
of mouse and human MsrA
Splice variants of mouse and human MsrA. (A) Schematic illustration of genomic structures of alternatively spliced MsrA
forms in humans and mice. Translation initiation sites are indicated by arrows. Exons are shown by boxes and are numbered.
The number of residues in each of the human and mouse forms is indicated on the right. (B) Alignment of mouse and human
mitochondrial MsrAs (the a form in A) and MsrA(S)s (the b form in A). The mitochondrial signal peptide is indicated in italics.
The catalytic cysteine in the GCFWG sequence and two cysteine residues in the last exon are highlighted. The arrow indicates
the last amino acid residue of exon 1.

tion, MsrA and MsrB proteins are often linked to each
other via direct domain fusion [7,8]. Single MsrA and
MsrB genes are present in yeast (e.g., Saccharomyces cerevisiae) and many other species (e.g., Caenorhabditis elegans
and Drosophila melanogaster) [7]. On the other hand, multiple genes of MsrA and MsrB have been found in members of the plant kingdom, Arabidopsis thaliana [9,10] and
Chlamydomonas reinhardtii [11].

Human and mouse genomes contain one MsrA and three
MsrB genes [12,13]. The three mammalian MsrB products
are located in different cellular compartments [13]. MsrB1
(also known as selenoprotein R or selenoprotein X) is a
cytosolic and nuclear protein. MsrB2 (also known as CBS1) is targeted to mitochondria. Human MsrB3 gives rise to
two forms generated by alternative first exon splicing,
which are targeted to the endoplasmic reticulum (ER) and
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Results and discussion

Figure 2 localization of the MsrA(S) form
Subcellular
Subcellular localization of the MsrA(S) form. (A) The
MsrA(S) expression construct (pMsrA(S)ΔGFP) was transfected into monkey kidney CV-1 cells. Transfected cells were
stained with anti-MsrA antibodies followed by secondary
anti-rabbit Cy5-conjugated antibodies. A set of two images is
shown: left panel, immunofluorescence; right panel, phase
contrast. (B) Green fluorescence images of CV-1 cells
expressing GFP-fused MsrA(S) (left) and control proteins
(pEGFP vector, right).

mitochondria [13], whereas there is no evidence for alternative first exon splicing in the mouse MsrB3 gene [14].
Although only a single MsrA gene is found in mammals
[15,16], the corresponding protein is localized in both
cytosol and mitochondria [17]. Recently, we reported that
the mouse MsrA containing the N-terminal mitochondrial
signal peptide is targeted to cytosol, nucleus, and mitochondria [18].
Alternative splicing is viewed as a major mechanism
responsible for multiplicity of protein forms in higher
eukaryotes [19]. Herein, we have found and characterized
a new splice form of MsrA in mouse and human. We also
report on alternative splicing of MsrA and MsrB genes in
insects. Our data are consistent with the idea that alternative splicing is a conserved mechanism to regulate subcellular distribution of methionine sulfoxide reductases in
mammals and other animals.

Alternative splicing variants of human and mouse MsrA
As indicated in the Background, only a single MsrA gene is
present in human, mouse, and rat genomes. The 374-kb
human and 317-kb mouse MsrA genes consist of 6 exons,
which generate a previously known form of the enzyme.
This MsrA form contains an N-terminal mitochondrial
signal peptide (known as the mitochondrial MsrA form
and shown as the a form in Figure 1A, [GenBank: mouse,
NM_026322; human, NM_012331]). However, its subcellular location is complex. In addition to mitochondria,
this protein is localized in cytosol and nucleus [18]. To
identify whether additional MsrA forms are present in
humans and mice, non-redundant and EST sequence
databases were searched using the known MsrA sequences
and the identified cDNAs were mapped on the genomic
sequences. Several alternatively spliced variants were
detected in both humans and mice. The most relevant
alternative spliced form was generated by alternative first
exon splicing (the b form in Figure 1A, [GenBank: mouse,
AK018338; human, AY690665]). It was mostly found in
brain ESTs, especially in early developmental stages (e.g.,
GenBank: F06683, H08256, R55838). This alternative
variant of mouse MsrA had an ORF of 191 residues (192
residues in humans), of which residues 5–191 corresponded to residues 47–233 of the mitochondrial MsrA
form (Figure 1B). This form was designated as MsrA(S).
Additional alternative forms were also detected, but these
were likely enzymatically inactive. For example, an alternative form devoid of exon 3 was identified (the c form in
Figure 1A, [GenBank: mouse, BC014738; human,
CK819754]). However, this form lacked the active site
and it was not detected (based on its lower molecular
weight) in several mouse tissues tested and in mouse
fibroblast NIH 3T3 cells by western blot analyses (data
not shown). An additional alternative form has also been
detected, in which exon 6, the last exon, was replaced with
a segment of an unknown gene [GenBank: CD 365491].
This form shared the first exon with the mitochondrial
MsrA form, but it is likely catalytically inactive due to lack
of the last exon which contains two cysteine residues critical for catalysis. Other detected forms contained just
some of the MsrA exons.
MsrA(S) is enzymatically active and localized in cytosol
and nucleus
We prepared a recombinant MsrA(S) form and characterized its catalytic activity. In parallel, we measured the
activity of the mitochondrial MsrA form for comparison.
The specific activity of MsrA(S) was 90 ± 7 nmol/min/mg
protein, which is 3-fold lower than that of the mitochondrial MsrA (260 ± 9 nmol/min/mg protein). The Km value
of MsrA(S) was 1.4 ± 0.3 mM, which is 4-fold higher than
that of the mitochondrial MsrA (0.37 ± 0.1 mM). To characterize subcellular localization of MsrA(S) in mamma-
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recent review by Hansel et al. [12] stated that an alternative form of MsrA mRNA was detected by RT-PCR in
human HEK 293 embryonic kidney cells.

Figure 3 blot analysis of MsrA forms
Western
Western blot analysis of MsrA forms. Cytosolic and
mitochondrial fractions from adult mouse brain, kidney, and
liver [18] were used. Equal amounts (30 μg) of proteins were
loaded on SDS-PAGE. Lanes 1 and 2, purified recombinant
His-tagged mitochondrial MsrA and His-tagged MsrA(S);
lanes 3 and 4, brain cytosolic and mitochondrial fractions;
lanes 5 and 6, kidney cytosolic and mitochondrial fractions;
lanes 7 and 8, liver cytosolic and mitochondrial fractions.

lian cells, we generated an expression construct
containing a full-length MsrA(S). The construct,
pMsrA(S)ΔGFP, was transfected into CV-1 cells, and
MsrA(S) location was determined by immunofluorescence using polyclonal MsrA antibodies. As shown in Figure 2, the protein was located in cytosol and nucleus. The
presence of MsrA(S) in these compartments was also confirmed by transfecting cells with a GFP-fusion construct,
pMsrA(S)-GFP.
Previously, we demonstrated that MsrA derived from the
protein form containing the mitochondrial signal peptide
is localized in cytosol and nucleus as well as in mitochondria and proposed that the subcellular localization of
MsrA is controlled on a post-translational level [18]. To
test whether MsrA(S) can be detected in mouse tissues, we
carried out western blot analyses. Based on size comparison with bacterially-expressed His-tagged mitochondrial
MsrA and MsrA(S) that served as internal controls, we did
not detect the MsrA(S) form in any of the mouse tissues
tested (brain, kidney, and liver) (Figure 3). However, the
MsrA with the higher molecular weight (derived from the
form containing the mitochondrial signal peptide) was
easily detected in cytosol and mitochondria of these tissues. As described previously [18], the cytosolic form was
slightly smaller than the form found in mitochondria, but
both of them were larger than the recombinant MsrA(S).
It is likely that the expression level of MsrA(S) is too low
to be detected or this form occurs in tissues not tested in
the current study. However, this form is clearly detectable
in EST databases in various organisms. In addition, a

Alternative splicing forms of MsrA and MsrB in drosophila
Single MsrA and MsrB genes were identified by BLAST
searches in D. melanogaster. Known MsrA [GenBank:
AF541958] and MsrB [GenBank: AY070627] proteins are
thought to be represented by cytosolic forms [20]. We
searched for possible additional forms of these proteins in
EST and cDNA sequence databases and identified an alternative splicing variant of MsrA [GenBank: AI064299] and
MsrB [GenBank: NM_169368]. These forms were generated by alternative first exon splicing. They contained a
predicted mitochondrial signal peptide at the N-terminus
(Figure 4B) and were predicted to be mitochondrial proteins. The genomic structure consisting of 4 exons and the
alternative splicing pattern of MsrA were similar to those
of MsrB (Figure 4A). However, as shown in deduced
amino acid sequences (Figure 4B), the translation initiation codon of the cytosolic MsrB was located in exon 2.

We suggest that the two alternatively spliced forms of D.
melanogaster MsrA and MsrB repair oxidized methionine
residues in the cytosol and mitochondria, which are the
locations that correspond to the occurrences of mammalian MsrA and MsrB in these compartments. We also analyzed additional insect sequences and found that the
alternative D. melanogaster forms are conserved in D.
yakuba and D. pseudoobscura. In addition, the predicted
cytosolic and mitochondrial forms of MsrA were represented by Glossina EST sequences. Although further studies on the expression levels of MsrA(S) and occurrence of
this protein form in various mouse tissues require more
sensitive assays that are currently not available (and the in
vivo proof of the occurrence of multiple MsrA forms in
fruit flies is also needed), it seems remarkable that the
same mechanism is used to regulate subcellular distribution of MsrA in such different organisms as fruit flies and
mammals, and that in each case, cytosolic and mitochondrial forms are synthesized.

Conclusion
This study shows that in some animals alternative splicing
is a common mechanism to regulate subcellular distribution of methionine sulfoxide reductases, allowing targeting the system for repair of oxidized methionine residues
to different compartments.

Methods
Preparation of recombinant alternatively spliced form of
mouse MsrA
To generate a C-terminal His-tagged MsrA(S) (an alternative form of MsrA), PCR was performed with primers ETSF
(5'-CGCCATATGTCTAAAGCCAAACACCATGT-
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Figure 4 splicing of D. melanogaster MsrA and MsrB genes
Alternative
Alternative splicing of D. melanogaster MsrA and MsrB genes. (A) Genomic structures of Drosophila MsrA and MsrB
genes. Translation initiation sites are indicated by arrows. Boxes indicate exons, which are numbered. Upper images show
organization of the cytosolic forms of MsrA (left) and MsrB (right), respectively, and lower images of the mitochondrial forms
of these proteins. (B) N-terminal amino acid sequences of alternatively spliced variants of MsrA and MsrB. Arrow indicates initiation of translation of cytosolic MsrB. However, this methionine is an internal residue in the mitochondrial MsrB form. Mitochondrial signal peptides are shown in italics.

CAGTGG-3') and ET-C (5'-ACACCTCGAGTTTTTTAATGGCCATCGGGC-3') using pET-MsrA(L)-His which
encodes a C-terminal His-tagged mitochondrial MsrA
[18]. The amplified fragment was cloned into the NdeI/
XhoI sites of pET21b, resulting in pET-MsrA(S). The mitochondrial MsrA and MsrA(S) proteins were expressed in E.
coli BL21(DE3) cells, purified using TALON metal affinity
resin (Clontech) and analyzed for purity by SDS-PAGE.
Protein concentration was determined by the Bradford
method using bovine serum albumin as a standard.
Determination of MsrA activity and Km
MsrA activity was assayed using dabsylated L-methionineS-sulfoxide as a substrate. A typical reaction mixture (100
μl) for reduction of dabsyl-methionine-S-sulfoxide to
dabsyl-Met contained 50 mM sodium phosphate (pH
7.5), 50 mM NaCl, 20 mM DTT, 200 μM substrate, and 1–
2 μg of purified proteins. The reaction was carried out at
37°C for 30 min, and stopped by adding 200 μl of acetonitrile. The reaction product, dabsyl-Met, was analyzed
by HPLC as described previously [20]. For determination

of Km, 50–800 μM substrate was used. The Km values were
determined using Lineweaver-Burk plots.
Constructs for subcellular localization
A GFP-fusion construct was prepared using pEGFP-N1
(Clontech). Full-length MsrA(S) was PCR-cloned into the
XhoI/EcoRI sites of pEGFP-N1, resulting in pMsrA(S)-GFP.
To create an MsrA(S)-only expression construct, a fulllength PCR fragment of MsrA(S) was cloned into the XhoI/
BsrGI sites of pEGFP-N1 that replaced the GFP coding
sequences. The
construct was designated
as
pMsrA(S)ΔGFP.
Fluorescence confocal microscopy
Transfections into monkey kidney CV-1 cells were performed using Lipofectamine (Invitrogen). For immunofluorescence staining of MsrA(S), cells were fixed as
described previously [18]. MsrA(S) proteins were stained
with polyclonal anti-rat MsrA antibodies (kindly provided
by Bertrand Friguet), followed by secondary anti-rabbit
Cy5-conjugated antibodies (Jackson ImmunoResearch
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Laboratories). Images were collected using a BioRad
MRC1024ES laser scanning microscope.
Western blotting
Polyclonal antibodies against rat MsrA were used to detect
MsrA proteins from mouse tissues and NIH 3T3 cells. Proteins were visualized using chemiluminescent peroxidase
substrate (Sigma).
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Searches for alternatively spliced forms of animal MsrA
and MsrB
To identify alternatively spliced forms of MsrA and MsrB,
BLAST searches were carried out using various MsrA and
MsrB sequences against NCBI non-redundant, EST and
genomic databases. Only forms represented by at least 2
cDNA sequences were further considered. To determine
gene structures, cDNA sequences were aligned with corresponding genomics sequences. Signal sequences were predicted with Signal P.

While this manuscript was under review, a study currently
in press reported 5'RACE (5' rapid amplification of cDNA
ends) using human retina cDNA and identified the
human MsrA(S) form [21]. This finding provides further
support for the occurrence of this form. In addition, an
additional macaque EST (CJ442767) was included in the
EST databases, which suggests the occurrence of an additional mammalian MsrA form with an alternative exon.
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